Agilent Announces Acquisition of BIOVECTRA
With the addition of BIOVECTRA, Agilent will expand its portfolio of CDMO services, add rapidly growing modalities, and bring world-class capabilities to support gene editing.
Agilent Technologies | 24/09/2024 | By Aishwarya | 198
Agilent Launches Biopharma CDx Services Lab to Accelerate Precision Medicine
The BCSL and Agilent’s assay development model will support drug development from early clinical studies through regulatory approval with efficient, flexible, and streamlined companion diagnostic development.
Agilent Technologies | 10/09/2024 | By Aishwarya | 118
Agilent Technologies to spend $725 M to double production capacity of therapeutic nucleic acids
Two new manufacturing lines—called Trains C and D—will be added to the company’s Frederick, Colorado, facility
Agilent Technologies | 11/01/2023 | By Sudeep Soparkar | 361
Agilent Technologies to organise Future Lab Summit in Ahmedabad
The summit will showcase an array of Agilent’s future-ready analytical solutions
<br />
Agilent Technologies | 30/06/2022 | By Sudeep Soparkar | 323
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy